News

Venture capital investment in women's health startups has experienced significant growth in recent years, with funding reaching new heights in 2024 according to the latest report from Silicon Valley Bank (SVB). According to SVB's 2025 Innovation in Women's Health Report, women's health investment hit US$2.6bn last year, surpassing 2023's total by nearly US$1bn. When including [...]

Dr Zibners is co-founder of Calla Lily Clinical Care (CLCC), a company changing the way women are treated for a range of medical conditions from infertility to cervical cancer to a healthy vaginal microbiome. The company has developed the Callavid platform for leak-free vaginal drug delivery. This week they are announcing a prestigious £1 million [...]

Researchers in the US are collaborating to create a new light-activated “smart” bomb to treat aggressive breast cancer. The team have combined their expertise to help develop new light-sensitive chemicals called cyanine-carborane salts that are used in photodynamic therapy, or PDT, to destroy metastatic breast cancer tumours in mice with minimal side effects. Sophia Lunt [...]

Excessive screen time among adolescents negatively impacts multiple aspects of sleep, which in turn increases the risk of depressive symptoms — particularly among girls, new research has found. Recently, the Swedish Public Health Agency published recommendations that adolescents use no more than two-to-three hours of daily leisure screen time, partly to promote better sleep. Previous [...]

Covera Health has announced the launch of Protect Her - an AI-powered solution designed to enhance early detection of critical health conditions predominantly impacting women ages 40 and up. Protect Her utilises latest advances in radiology AI to identify early signs of breast cancer, cardiovascular disease and osteoporosis during routine scans that women are already [...]

Oncology liquid biopsy company Vortex Biotech Holdings has announced a collaborative agreement with the University of Maryland Baltimore (UMB) to advance clinical investigations of Vortex's technology alongside UMB's Tetherchip research. Vortex’s liquid biopsy technology works by automating the capture and collection of Circulating Tumour Cells (CTCs) directly from whole blood, a challenging task because of [...]

By Aron Solomon, Pulitzer Prize-nominated writer and chief strategy officer for Amplify For decades, Depo-Provera was marketed as a convenient, long-lasting birth control option for women who want to take control of their reproductive health without the hassle of daily pills. It was sold as a solution—an easy shot every three months that promised reliability [...]

The Diagnostic Tampon invented by gynaecological health company Daye has been chosen to be part of the NHS Innovation Accelerator (NIA). The Accelerator recognises innovations that address the NHS's most urgent priorities and have demonstrated potential for widespread adoption to improve patient outcomes nationwide. The Diagnostic Tampon utilises cutting-edge PCR testing technology to allow women [...]

Hale House is set to position the Harley Street Health District as a leading cluster for Health innovation. The £52 million investment is a clear reflection of Howard de Walden’s ongoing commitment to advancing healthcare and solidifying the district as a destination for healthcare excellence long into the future. Hale House is a pioneering development [...]

A new study has revealed that hormonal contraceptive initiation postpartum was associated with an instantaneous increased risk of developing depression. The study set out to investigate whether taking hormonal contraceptive (HC) post partum is associated with the risk of developing depression within 12 months after delivery. Findings from the study of 610 038 first-time mothers [...]